All KLOW certificates

KLOW 80 mg Certificate of Analysis Batch APL-KLOW80-2610-05

KLOW 80 mg from batch APL-KLOW80-2610-05 was analysed on 23 October 2026 and measured 99.45% combined purity across GHK-Cu, KPV, TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity
99.45%
Components
GHK-Cu, KPV, TB-500, BPC-157
Result
All 5 tests passed
Tested
23 October 2026
Method
HPLC / Mass Spectrometry
Net content
79.71 mg

Independent verification

KLOW 80 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.40% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-KLOW80-2608-01, net content GHK-Cu 51.38 mg, KPV 10.58 mg, BPC-157 10.44 mg, TB-500 10.58 mg, verification code OZ-HPLCMS-BJ29.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 5

Certificate of Analysis KLOW 80 mg Batch APL-KLOW80-2610-05
Compound Mix
KLOW
Lot Number
APL-KLOW80-2610-05
Analysis Date
23 October 2026
Method
HPLC / Mass Spectrometry
Purity
99.45%
Net Content
79.71 mg
KLOW vial
Net Content
  • GHK-Cu50.00 mg
  • KPV10.10 mg
  • TB-50010.11 mg
  • BPC-1579.99 mg
Form
Lyophilised Powder
Manufactured
October 2026
Issued
24 October 2026
Document ID
APL-COA-KLOW80-2610-05
Verification Code
Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm01883755637500123456 min 1.2971.481GHK-Cu1.847KPV2.2092.993TB-5003.287BPC-1573.7535.089

4 components resolved on a single gradient and assigned by retention time against individually run reference standards. Purity is reported as their combined peak area; the remaining 4 integrated peaks are unassigned process impurities. Component share of total peak area reflects UV response at 214 nm, not the mass ratio in the vial.

Peak List

Peaks detected: 8
#Time (min)Area% AreaAssignment
11.29714,3690.168—
21.4813,969,31746.411GHK-Cu
31.8471,976,83323.113KPV
42.20911,1190.130—
52.993949,11611.097TB-500
63.2871,610,51218.830BPC-157
73.75315,9080.186—
85.0895,5590.065—

Analytical Results

TestSpecificationResultStatus
AppearanceBlue/Blue-Green Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined99.45%PASS
Total Peptide Content95–105%99.0%PASS
Endotoxins<0.5 EU/mg<0.20 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 5

GHK-Cu

PubChem CID: 133697840 · CAS Number: 49557-75-7

Formula: C14H24CuN6O4 · MW: 403.92 g/mol · In this vial: 50.00 mg

SequenceGly-His-Lys

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
405404.931.53
427426.872.89

Detection assignment: GHK-Cu

Collected Mass Spectrum

Intensity ×107

01234100200300400500600700800 m/z 405427

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 5

KPV

PubChem CID: 125672 · CAS Number: 67727-97-3

Formula: C16H30N4O4 · MW: 342.4 g/mol · In this vial: 10.10 mg

SequenceLys-Pro-Val

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
343342.981.18
365364.470.83

Detection assignment: KPV

Collected Mass Spectrum

Intensity ×107

00.511.50100200300400500600700 m/z 343364

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 4 of 5

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 10.11 mg

SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa, N-terminally acetylated)

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
828828.520.79
994993.921.68
12421242.10.65

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×107

00.511.52500700900110013001500 m/z 8299941242

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 5 of 5

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 9.99 mg

SequenceGEPPPGKPADDAGLV

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
474473.860.5
711710.971.77
142114210.29

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×107

00.511.52020040060080010001200140016001800 m/z 4747111421

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View KLOW in the catalogueHow to read this certificate